Cite
Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression.
MLA
Wang, I.Han, et al. “Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression.” Cancers, vol. 12, no. 5, May 2020, p. 1088. EBSCOhost, https://doi.org/10.3390/cancers12051088.
APA
Wang, I.-H., Huang, T.-T., Chen, J.-L., Chu, L.-W., Ping, Y.-H., Hsu, K.-W., Huang, K.-H., Fang, W.-L., Lee, H.-C., Chen, C.-F., Liao, C.-C., Hsieh, R.-H., & Yeh, T.-S. (2020). Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression. Cancers, 12(5), 1088. https://doi.org/10.3390/cancers12051088
Chicago
Wang, I-Han, Tzu-Ting Huang, Ji-Lin Chen, Li-Wei Chu, Yueh-Hsin Ping, Kai-Wen Hsu, Kuo-Hung Huang, et al. 2020. “Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression.” Cancers 12 (5): 1088. doi:10.3390/cancers12051088.